Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced its schedule of events at the American College of Cardiology (ACC) 2012 Scientific Sessions in Chicago, IL.
At ACC 2012, there will be six Impella poster presentations, five Impella case reviews and four oral Impella presentations. See below for the full schedule of Impella-related presentations at the show.
In addition, Abiomed will be releasing new automated flow control features at this year's ACC show. The new enhancements further simplify user start-up, operation and patient management, and will be available for hands-on demonstration and simulation at Abiomed ACC booth #9063.
Live Case Updates
The company anticipates live cases utilizing Impella to be broadcast from the participating live case sites in the McCormick Place Convention Center. Further details will be disclosed the day of the scheduled cases, as patient status is relative to change.
ACC 2012 SCHEDULE OF EVENTS
SATURDAY, MARCH 24
8:45 a.m.
- Session Title: Pathogenic and Therapeutic Insights from
Experimental Heart Failure Models
- "Mechanical Unloading with Left Ventricular Assist Device after
Acute Myocardial Infarction Prevents Adverse Cardiac Remodeling"
Presenter: Xufeng Wei, M.D.
ACC Oral Contributions: Session 906
McCormick Place South, S404
- "Mechanical Unloading with Left Ventricular Assist Device after
Acute Myocardial Infarction Prevents Adverse Cardiac Remodeling"
9:30 a.m.
- Session Title: Outcomes of Patients Treated with PCI
- "Cost-effectiveness and Quality of Life Improvements: Hemodynamic
Support Devices in High Risk Patients Receiving PCI"
Presenter: Brijeshwar Maini, M.D.
ACC Poster Session: Poster # 241
McCormick Place South, Hall A
- "Cost-effectiveness and Quality of Life Improvements: Hemodynamic
Support Devices in High Risk Patients Receiving PCI"
SUNDAY, MARCH 25
11:00 a.m.
- Session Title: Acute Coronary Syndromes: Therapy IV
- "Cost-Effectiveness of Impella Hemodynamic Support in the Emergent
Care Patient Group"
Presenter: Brijeshwar Maini, M.D.
ACC Poster Session: Poster # 564
McCormick Place South, Hall A
- "Cost-Effectiveness of Impella Hemodynamic Support in the Emergent
Care Patient Group"
12:45 p.m.
- Session Title: Multi-Vessel and Hemodynamic Support Case Reviews
- "Effusive-Constrictive Pericarditis"
Presenter: David Bartov, M.D.
ACC-i2 Meet the Experts: Session 2310
McCormick Place South, S102c
- "Effusive-Constrictive Pericarditis"
MONDAY, MARCH 26
8:15 a.m.
- Session Title: Multi-Disciplinary Management of the Failing Heart:
Team Based Evaluation and Therapy of Advanced Heart Disease
- "Case Presentation 1"
Presenter: Brian P. O'Neill, M.D.
ACC-i2 Special Session: Session 2121
McCormick Place South, S102c
- "Case Presentation 1"
8:30 a.m.
- Session Title: Shock in ACS
- "Role of LV Assist Device in Cardiogenic Shock"
Presenter: John M. Lasala, M.D.
ACC Symposium Session: Session 676
McCormick Place South, S401a
- "Role of LV Assist Device in Cardiogenic Shock"
9:30 a.m.
- Session Title: Mechanical Circulatory Support: Innovations and
Outcomes
- "First Clinical Evaluation of a Novel Percutaneous Right
Ventricular Assist Device: The Impella RP"
Presenter: Anson Cheung, M.D.
ACC Poster Session: Poster # 11
McCormick Place South, Hall A
- "First Clinical Evaluation of a Novel Percutaneous Right
Ventricular Assist Device: The Impella RP"
9:30 a.m.
- Session Title: Ventricular Arrhythmias in 2012: From the J-Wave and
Early Repolarization to LVADs
- "Role of Percutaneous Left Ventricular Assist Devices in Unstable
Ventricular Arrhythmia Ablation"
Presenter: Madhu Reddy, M.D.
ACC Poster Session: Poster # 356
McCormick Place South, Hall A
- "Role of Percutaneous Left Ventricular Assist Devices in Unstable
Ventricular Arrhythmia Ablation"
11:00 a.m.
- Session Title: When PCI Is Not a Slam Dunk
- "The PROTECT II Study"
Presenter: Jeffrey J. Popma, M.D.
ACC Poster Session: Poster # 295
McCormick Place South, Hall A
- "The PROTECT II Study"
11:15 a.m.
- Session Title: Multi-Disciplinary Management of the Failing Heart:
Team Based Evaluation and Therapy of Advanced Heart Disease II
- "Case Presentation 4"
Presenter: David Bartov, M.D.
ACC-i2 Special Session: Session 2122
McCormick Place South, S102c
- "Case Presentation 4"
12:15 p.m.
- Session Title: Shock and Hemodynamic Support Case Reviews
- 12:33 p.m. -12:43 p.m.
"Percutaneous Coronary Intervention With Left Ventricular Support From A 2.5 Impella Via A Left Axillary Chimney"
Presenter: Syed Tanveer Rab, M.D. - 12:51 p.m. - 1:01 p.m.
"A Case of Acute Septal Rupture Followed by Right Ventricular Free Wall Rupture in a Patient with Takotsubo Cardiomyopathy Managed with Percutaneous Left Ventricular Support"
Presenter: Joanne Ilustre, M.D. - 1:09 p.m. - 1:19 p.m.
"Percutaneous Ventricular Support: A 56 Year-Old Man With Acute Fulminant Myocarditis"
Presenter: Andrew Edward Kott, M.D.
ACC-i2 Meet the Experts: Session 2315
McCormick Place South, S102
- 12:33 p.m. -12:43 p.m.
2:45 p.m.
- Session Title: State of the Art STEMI: All You Need to Know
- "Mechanical Support for Treatment of Cardiogenic Shock and
Hemodynamic Instability"
Presenter: John M. Lasala, M.D.
ACC-i2 Symposium Session: Session 2638
McCormick Place South, S106b
- "Mechanical Support for Treatment of Cardiogenic Shock and
Hemodynamic Instability"
3:57 p.m.
- Session Title: ACS: New Insights and Novel Therapies
- "Adjunctive Therapies to Mitigate Ischemia-Reperfusion Injury"
Presenter: William W. O'Neill, M.D.
ACC-i2 Symposium Session: Session 2643
McCormick Place South, S106b
- "Adjunctive Therapies to Mitigate Ischemia-Reperfusion Injury"
ABOUT ABIOMED
Based in Danvers, Massachusetts, Abiomed, Inc. is a leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Our products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping of the heart. For additional information please visit: www.abiomed.com.
FORWARD-LOOKING STATEMENTS
This Release contains forward-looking statements, including statements regarding development of Abiomed's existing and new products, the Company's progress toward commercial growth, and future opportunities. The Company's actual results may differ materially from those anticipated in these forward-looking statements based upon a number of factors, including uncertainties associated with development, testing and related regulatory approvals, anticipated future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological change, government regulation, future capital needs and uncertainty of additional financing, and other risks and challenges detailed in the Company's filings with the Securities and Exchange Commission, including the Annual Report filed on Form 10-K and most recent Form 10-Q. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this Release. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this Release or to reflect the occurrence of unanticipated events.
Contacts:
Abiomed
Aimee Maillett, 978-646-1553
Corporate Communications
Manager
amaillett@abiomed.com